Cefmenoxime (hydrochloride)

Cefmenoxime (SCE-1365) hydrochloride is a new semisynthetic cephalosporin antibiotic. Cefmenoxime has antibacterial activity against a wide variety of gram-positive and gram-negative bacteria[1][2].

Product Specifications

CAS Number

[75738-58-8]

Product Name Alternative

SCE-1365 (hydrochloride)

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

Antibiotic; Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Cefmenoxime-hydrochloride.html

Purity

99.29

Solubility

DMSO : 65 mg/mL (ultrasonic; warming) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

O=C(C(N12)=C(CSC3=NN=NN3C)CS[C@]2([H])[C@H](NC(/C(C4=CSC(N)=N4)=N\OC)=O)C1=O)O.[0.5HCl]

Molecular Formula

C16H17N9O5S3.1/2 HCl

Molecular Weight

529.79

Precautions

H315, H319, H335

References & Citations

[1]Stamm JM, et, al. Antimicrobial activity of cefmenoxime (SCE-1365) . Antimicrob Agents Chemother. 1981 Mar;19 (3) :454-60.|[2]Tatara O, et, al. Synergistic effects of romurtide and cefmenoxime against experimental Klebsiella pneumonia in mice. Antimicrob Agents Chemother. 1992 Jan;36 (1) :167-71.